EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genomic monitoring of SARS‐CoV‐2 variants using sentinel SARI hospital surveillance

Sarah Denayer iD, François E Dufrasne, Bert Monsieurs, Reinout van Eycken, Sarah Houben, Lucie Seyler, Thomas Demuyser, Els van Nedervelde, Marc Bourgeois, Bénédicte Delaere, Koen Magerman, Door Jouck und 17 weitere

Influenza and Other Respiratory Viruses · 2023

DOI: 10.1111/irv.13202 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Influenza and Other Respiratory Viruses, 2023. Verfasst von Sarah Denayer und 28 weiteren Autor:innen. Beteiligte Einrichtung: Viral Diseases, National Influenza Centre, Scientific Directorate of Infectious Diseases in Humans Sciensano Ukkel Belgium. Hauptthemen laut MEDLINE: COVID-19, Pneumonia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Belgische Federale Overheidsdiensten.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

To support the COVID‐19 pandemic response, many countries, including Belgium, implemented baseline genomic surveillance (BGS) programs aiming to early detect and characterize new SARS‐CoV‐2 variants. In parallel, Belgium maintained a sentinel network of six hospitals that samples patients with severe acute respiratory infections (SARI) and integrated SARS‐CoV‐2 detection within a broader range of respiratory pathogens. We evaluate the ability of the SARI surveillance to monitor general trends and early signals of viral genetic evolution of SARS‐CoV‐2 and compare it with the BGS as a reference model.

Methods

Nine‐hundred twenty‐five SARS‐CoV‐2 positive samples from patients fulfilling the Belgian SARI definition between January 2020 and December 2022 were sequenced using the ARTIC Network amplicon tiling approach on a MinION platform. Weekly variant of concern (VOC) proportions and types were compared to those that were circulating between 2021 and 2022, using 96,251 sequences of the BGS.

Results

SARI surveillance allowed timely detection of the Omicron (BA.1, BA.2, BA.4, and BA.5) and Delta (B.1.617.2) VOCs, with no to 2 weeks delay according to the start of their epidemic growth in the Belgian population. First detection of VOCs B.1.351 and P.1 took longer, but these remained minor in Belgium. Omicron BA.3 was never detected in SARI surveillance. Timeliness could not be evaluated for B.1.1.7, being already major at the start of the study period.

Conclusions

Genomic surveillance of SARS‐CoV‐2 using SARI sentinel surveillance has proven to accurately reflect VOCs detected in the population and provides a cost‐effective solution for long‐term genomic monitoring of circulating respiratory viruses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19PneumoniaHumansSARS-CoV-2PandemicsSentinel SurveillanceGenomicsHospitals

Stichwörter der Autor:innen

SARI surveillanceSARS‐CoV‐2genomic surveillanceinfluenzapandemic preparednessrespiratory viruses

Autor:innen und Institutionen

  • Viral Diseases, National Influenza Centre, Scientific Directorate of Infectious Diseases in Humans Sciensano Ukkel Belgium.
  • Observational Clinical Trials, Scientific Directorate of infectious Diseases in Humans Sciensano Ukkel Belgium.
  • Department of Internal Medicine and Infectiology, Universitair Ziekenhuis Brussel (UZB) Vrije Universiteit Brussel (VUB) Brussels Belgium.
  • Department of Microbiology and Infection Control, Universitair Ziekenhuis Brussel (UZB) Vrije Universiteit Brussel (VUB) Brussels Belgium.
  • AIMS Lab, Center for Neurosciences, Faculty of Medicine and Pharmacy Vrije Universiteit Brussel (VUB) Brussels Belgium.
  • CHU UCL Namur, site Mont-Godinne Yvoir Belgium.

ORCID-Profile: Sarah Denayer, Cyril Barbezange

Förderung

  • Belgische Federale Overheidsdiensten

Zitieren

APA

Denayer, S., Dufrasne, F. E., Monsieurs, B., van Eycken, R., Houben, S., Seyler, L., Demuyser, T., van Nedervelde, E., Bourgeois, M., Delaere, B., Magerman, K., Jouck, D., Lissoir, B., Sion, C., Reynders, M., Petit, E., Dauby, N., Hainaut, M., Laenen, L., …, & van Gucht, S. (2023). Genomic monitoring of SARS‐CoV‐2 variants using sentinel SARI hospital surveillance. Influenza and Other Respiratory Viruses. https://doi.org/10.1111/irv.13202

Vancouver

Denayer S, Dufrasne FE, Monsieurs B, van Eycken R, Houben S, Seyler L, et al. Genomic monitoring of SARS‐CoV‐2 variants using sentinel SARI hospital surveillance. Influenza and Other Respiratory Viruses. 2023. doi:10.1111/irv.13202

BibTeX
@article{Denayer2023,
  author = {Denayer, Sarah and Dufrasne, François E and Monsieurs, Bert and van Eycken, Reinout and Houben, Sarah and Seyler, Lucie and Demuyser, Thomas and van Nedervelde, Els and Bourgeois, Marc and Delaere, Bénédicte and Magerman, Koen and Jouck, Door and Lissoir, Bénédicte and Sion, Catherine and Reynders, Marijke and Petit, Evelyn and Dauby, Nicolas and Hainaut, Marc and Laenen, Lies and Maes, Piet and Baele, Guy and Dellicour, Simon and Cuypers, Lize and André, Emmanuel and Couvreur, Simon and Brondeel, Ruben and Barbezange, Cyril and Bossuyt, Nathalie and van Gucht, Steven},
  title = {Genomic monitoring of SARS‐CoV‐2 variants using sentinel SARI hospital surveillance},
  journal = {Influenza and Other Respiratory Viruses},
  year = {2023},
  doi = {10.1111/irv.13202}
}
Kostenlos starten →